Thalidomide and dexamethasone for newly diagnosed multiple myeloma: Is this really the standard of care?

被引：2
|
作者：
Nabhan, Chadi [1 ]
Bitran, Jacob D. [1 ]
机构：
[1] Lutheran Gen Hosp, Inst Canc, Park Ridge, IL 60068 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
10.1200/JCO.2006.06.3115
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2967 / 2968
页数：2
相关论文
共 50 条
  • [31] Thalidomide plus dexamethasone for untreated newly diagnosed multiple myeloma patients and deep vein thrombosis.
    Jimenez, Victor H.
    Dominguez, Virginia J.
    Reynoso, Eduardo E.
    BLOOD, 2006, 108 (11) : 362B - 362B
  • [32] Osteonecrosis of the jaws in newly diagnosed multiple myeloma patients treated with zoledronic acid and thalidomide-dexamethasone
    Tosi, Patrizia
    Zamagni, Elena
    Cangini, Delia
    Tacchetti, Paola
    Di Raimondo, Francesco
    Catalano, Lucio
    D'Arco, Alfonso
    Ronconi, Sonia
    Cellini, Claudia
    Offidani, Massimo
    Perrone, Giulia
    Ceccolini, Michela
    Brioli, Annamaria
    Tura, Sante
    Baccarani, Michele
    Cavo, Michele
    BLOOD, 2006, 108 (12) : 3951 - 3952
  • [33] Higher single dose of bortezomib plus thalidomide and dexamethasone is a promising therapy for newly diagnosed multiple myeloma
    Xu, Peipei
    Zhou, Rongfu
    Xu, Jingyan
    Ouyang, Jian
    Shao, Xiaoyan
    Chen, Bing
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 (05) : 2099 - 2106
  • [34] Setting the standard for newly diagnosed multiple myeloma
    Jacob Laubach
    Paul G. Richardson
    Kenneth Anderson
    Nature Reviews Clinical Oncology, 2011, 8 : 255 - 256
  • [35] Bortezomib, dexamethasone plus thalidomide for treatment of newly diagnosed multiple myeloma patients with or without renal impairment
    Yang, Guangzhong
    Chen, Wenming
    Wu, Yin
    CHINESE JOURNAL OF CANCER RESEARCH, 2013, 25 (02) : 155 - 160
  • [36] Coagulation profiles and thromboembolic events of bortezomib plus thalidomide and dexamethasone therapy in newly diagnosed multiple myeloma
    Shen, Yunfeng
    Zhou, Xin
    Wang, Zhi
    Yang, Guohua
    Jiang, Yuanqiang
    Sun, Chao
    Wang, Jing
    Tong, Yi
    Guo, Hongfeng
    LEUKEMIA RESEARCH, 2011, 35 (02) : 147 - 151
  • [37] Phase II Trial of Syncopated Thalidomide, Lenalidomide, and Weekly Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma
    Tufail, Madiha
    Siegel, David S.
    McBride, Laura
    Bilotti, Elizabeth
    Bello, Erica
    Anand, Palka
    Olivo, Karly
    Bendarz, Urszula
    McNeill, Ann
    Vesole, David H.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2012, 12 (03): : 186 - 190
  • [38] Thalidomide, lenalidomide and bortezomib in the management of newly diagnosed multiple myeloma
    Laubach, Jacob P.
    Schlossman, Robert L.
    Mitsiades, Constantine S.
    Anderson, Kenneth C.
    Richardson, Paul G.
    EXPERT REVIEW OF HEMATOLOGY, 2011, 4 (01) : 51 - 60
  • [39] Bortezomib Plus Thalidomide for Newly Diagnosed Multiple Myeloma in China
    Chen, Shi-Lun
    Jiang, Bin
    Qiu, Lu-Gui
    Yu, Li
    Zhong, Yu-Ping
    Gao, Wen
    ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY, 2010, 293 (10): : 1679 - 1684
  • [40] Thalidomide/Dexamethasone Induction Therapy in Newly Diagnosed Myeloma Patients with Renal Failure
    Tosi, P.
    Tacchetti, P.
    Zamagni, E.
    Tacchetti, P.
    Ceccolini, M.
    Perrone, G.
    Brioli, A.
    Pallotti, M. C.
    Petrucci, A.
    Baccarani, M.
    Cavo, M.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S30 - S30
12345